

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54806635 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.54806635 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.46597267 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.46597267 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.79135484 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.31954112 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29842699 |
| 8 | cysteine metabolic process (GO:0006534) | 5.26984869 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.26919293 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.15468117 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.15468117 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.15468117 |
| 13 | urea metabolic process (GO:0019627) | 5.08630251 |
| 14 | urea cycle (GO:0000050) | 5.08630251 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.07909091 |
| 16 | lysine metabolic process (GO:0006553) | 5.05592324 |
| 17 | lysine catabolic process (GO:0006554) | 5.05592324 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.02466523 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.90431122 |
| 20 | protein carboxylation (GO:0018214) | 4.90431122 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.86858114 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.86353830 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.73624657 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.65176661 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.62739086 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.60786176 |
| 27 | desmosome organization (GO:0002934) | 4.58106893 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.56351046 |
| 29 | skin morphogenesis (GO:0043589) | 4.49542879 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.49043112 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.46179080 |
| 32 | homocysteine metabolic process (GO:0050667) | 4.44661866 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.43655263 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.37261199 |
| 35 | regulation of cholesterol homeostasis (GO:2000188) | 4.32917964 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.27016206 |
| 37 | hemidesmosome assembly (GO:0031581) | 4.26630630 |
| 38 | phospholipid efflux (GO:0033700) | 4.23651575 |
| 39 | Golgi transport vesicle coating (GO:0048200) | 4.21246766 |
| 40 | COPI coating of Golgi vesicle (GO:0048205) | 4.21246766 |
| 41 | bile acid metabolic process (GO:0008206) | 4.20268696 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.19127289 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.19127289 |
| 44 | protein localization to endosome (GO:0036010) | 4.18991769 |
| 45 | regulation of complement activation (GO:0030449) | 4.17035978 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.16673460 |
| 47 | cell adhesion mediated by integrin (GO:0033627) | 4.09942675 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.07376159 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.05424204 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 3.99780591 |
| 51 | negative regulation of sterol transport (GO:0032372) | 3.99780591 |
| 52 | epithelial cell-cell adhesion (GO:0090136) | 3.98454086 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.94948823 |
| 54 | cellular modified amino acid catabolic process (GO:0042219) | 3.86203737 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 3.85122861 |
| 56 | glutamate metabolic process (GO:0006536) | 3.78929862 |
| 57 | bile acid and bile salt transport (GO:0015721) | 3.78437804 |
| 58 | glycine metabolic process (GO:0006544) | 3.77882024 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 3.77777204 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 3.76635804 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.75912771 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 3.75912771 |
| 63 | macromolecular complex remodeling (GO:0034367) | 3.75912771 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 3.75325689 |
| 65 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.74991825 |
| 66 | protein retention in ER lumen (GO:0006621) | 3.70707680 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.69222222 |
| 68 | coenzyme catabolic process (GO:0009109) | 3.68014923 |
| 69 | drug catabolic process (GO:0042737) | 3.66818260 |
| 70 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65538644 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 3.62831820 |
| 72 | cellular glucuronidation (GO:0052695) | 3.59851860 |
| 73 | arginine metabolic process (GO:0006525) | 3.58402448 |
| 74 | cell-substrate junction assembly (GO:0007044) | 3.57165492 |
| 75 | intestinal cholesterol absorption (GO:0030299) | 3.56525008 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 3.56193425 |
| 77 | aspartate family amino acid catabolic process (GO:0009068) | 3.56036114 |
| 78 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.55616571 |
| 79 | fibrinolysis (GO:0042730) | 3.55230985 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 3.54194074 |
| 81 | cholesterol efflux (GO:0033344) | 3.52730281 |
| 82 | phospholipid homeostasis (GO:0055091) | 3.50078640 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 3.49761356 |
| 84 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.48298583 |
| 85 | urate metabolic process (GO:0046415) | 3.48088530 |
| 86 | drug transmembrane transport (GO:0006855) | 3.47050782 |
| 87 | fatty acid oxidation (GO:0019395) | 3.45899820 |
| 88 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.45390541 |
| 89 | flavonoid metabolic process (GO:0009812) | 3.43659054 |
| 90 | basement membrane organization (GO:0071711) | 3.43184628 |
| 91 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.42058133 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.41571505 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.41254260 |
| 94 | 2-oxoglutarate metabolic process (GO:0006103) | 3.40068644 |
| 95 | cholesterol homeostasis (GO:0042632) | 3.39957484 |
| 96 | ethanol oxidation (GO:0006069) | 3.38516133 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.38312017 |
| 98 | sterol homeostasis (GO:0055092) | 3.37679254 |
| 99 | lipid oxidation (GO:0034440) | 3.36755905 |
| 100 | organic acid catabolic process (GO:0016054) | 3.36150142 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.36150142 |
| 102 | carnitine metabolic process (GO:0009437) | 3.35877026 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.34721587 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.33697355 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.33013433 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.33013433 |
| 107 | fatty acid catabolic process (GO:0009062) | 3.31601652 |
| 108 | adherens junction assembly (GO:0034333) | 3.29962990 |
| 109 | regulation of early endosome to late endosome transport (GO:2000641) | 3.29641772 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 3.28845135 |
| 111 | monocarboxylic acid catabolic process (GO:0072329) | 3.28445898 |
| 112 | positive regulation of extracellular matrix organization (GO:1903055) | 3.28246721 |
| 113 | response to mercury ion (GO:0046689) | 3.26788530 |
| 114 | serine family amino acid biosynthetic process (GO:0009070) | 3.26558867 |
| 115 | cellular biogenic amine catabolic process (GO:0042402) | 3.25425134 |
| 116 | amine catabolic process (GO:0009310) | 3.25425134 |
| 117 | lipoprotein metabolic process (GO:0042157) | 3.24279095 |
| 118 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.24030127 |
| 119 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.22959995 |
| 120 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.20146614 |
| 121 | substrate-dependent cell migration (GO:0006929) | 3.19027228 |
| 122 | semaphorin-plexin signaling pathway (GO:0071526) | 3.17993592 |
| 123 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.15566460 |
| 124 | cell-substrate adherens junction assembly (GO:0007045) | 3.14977847 |
| 125 | focal adhesion assembly (GO:0048041) | 3.14977847 |
| 126 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.12961180 |
| 127 | endodermal cell differentiation (GO:0035987) | 3.08613954 |
| 128 | peptidyl-proline hydroxylation (GO:0019511) | 2.97802359 |
| 129 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.97464150 |
| 130 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.95966583 |
| 131 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.95023872 |
| 132 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.94066224 |
| 133 | negative regulation of fatty acid transport (GO:2000192) | 2.91002946 |
| 134 | barbed-end actin filament capping (GO:0051016) | 2.89306265 |
| 135 | regulation of water loss via skin (GO:0033561) | 2.87837572 |
| 136 | protein hydroxylation (GO:0018126) | 2.85745795 |
| 137 | pinocytosis (GO:0006907) | 2.84023120 |
| 138 | endothelial cell morphogenesis (GO:0001886) | 2.75430520 |
| 139 | gap junction assembly (GO:0016264) | 2.74604496 |
| 140 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.74058598 |
| 141 | mesodermal cell differentiation (GO:0048333) | 2.72985125 |
| 142 | activation of Rac GTPase activity (GO:0032863) | 2.71793702 |
| 143 | atrioventricular valve morphogenesis (GO:0003181) | 2.71789087 |
| 144 | apoptotic cell clearance (GO:0043277) | 2.69563140 |
| 145 | regulation of cardioblast differentiation (GO:0051890) | 2.68592719 |
| 146 | endothelial cell chemotaxis (GO:0035767) | 2.67216903 |
| 147 | stress fiber assembly (GO:0043149) | 2.67183591 |
| 148 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.66703290 |
| 149 | regulation of plasminogen activation (GO:0010755) | 2.65305932 |
| 150 | protein maturation by protein folding (GO:0022417) | 2.62042745 |
| 151 | cell-cell junction maintenance (GO:0045217) | 2.61408909 |
| 152 | positive regulation of osteoblast proliferation (GO:0033690) | 2.61395592 |
| 153 | low-density lipoprotein particle clearance (GO:0034383) | 2.61075919 |
| 154 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59019272 |
| 155 | hypotonic response (GO:0006971) | 2.58742342 |
| 156 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.58572790 |
| 157 | wound healing, spreading of epidermal cells (GO:0035313) | 2.52095847 |
| 158 | hyaluronan catabolic process (GO:0030214) | 2.51612046 |
| 159 | glucose 6-phosphate metabolic process (GO:0051156) | 2.51404426 |
| 160 | 4-hydroxyproline metabolic process (GO:0019471) | 2.49356511 |
| 161 | adhesion of symbiont to host (GO:0044406) | 2.46440925 |
| 162 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.45807027 |
| 163 | cochlea morphogenesis (GO:0090103) | 2.45689075 |
| 164 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.44601383 |
| 165 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.44470899 |
| 166 | embryo implantation (GO:0007566) | 2.43549412 |
| 167 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.42849458 |
| 168 | regulation of extracellular matrix organization (GO:1903053) | 2.42395115 |
| 169 | apoptotic process involved in morphogenesis (GO:0060561) | 2.42386938 |
| 170 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.40800569 |
| 171 | proline biosynthetic process (GO:0006561) | 2.39291684 |
| 172 | endocytic recycling (GO:0032456) | 2.37780191 |
| 173 | regulation of extracellular matrix disassembly (GO:0010715) | 2.37607034 |
| 174 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.36771543 |
| 175 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.36744083 |
| 176 | establishment of skin barrier (GO:0061436) | 2.36405361 |
| 177 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.35594424 |
| 178 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.35151196 |
| 179 | surfactant homeostasis (GO:0043129) | 2.34368781 |
| 180 | actin filament bundle organization (GO:0061572) | 2.33327465 |
| 181 | actin filament bundle assembly (GO:0051017) | 2.33327465 |
| 182 | regulation of establishment of planar polarity (GO:0090175) | 2.32713267 |
| 183 | positive regulation of nuclease activity (GO:0032075) | 2.28748062 |
| 184 | endocardial cushion development (GO:0003197) | 2.28085695 |
| 185 | wound healing, spreading of cells (GO:0044319) | 2.27260158 |
| 186 | lung vasculature development (GO:0060426) | 2.26737985 |
| 187 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.26224812 |
| 188 | cellular copper ion homeostasis (GO:0006878) | 2.25840489 |
| 189 | protein localization to microtubule (GO:0035372) | 2.25833160 |
| 190 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.25664657 |
| 191 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.24702869 |
| 192 | regulation of metalloenzyme activity (GO:0048552) | 2.24470983 |
| 193 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.23950418 |
| 194 | diaphragm development (GO:0060539) | 2.23634824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.16334768 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.63615635 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.90307899 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24409017 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80346699 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.36868092 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.25601392 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.48931910 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.20106370 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77359769 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.50658335 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45416722 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34418909 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.27411369 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.09478525 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.99163806 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91356453 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.90485438 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76619846 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.74452968 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74064091 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72637388 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72398656 |
| 24 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.67781985 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66022280 |
| 26 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.63312805 |
| 27 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.63312805 |
| 28 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.63132501 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57499102 |
| 30 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54283066 |
| 31 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51730964 |
| 32 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.51109761 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49636981 |
| 34 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.49037321 |
| 35 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.43574075 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41054223 |
| 37 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40649077 |
| 38 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40079091 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37591941 |
| 40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36597934 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35493994 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33863016 |
| 43 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.30575168 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30411545 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29436412 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26686124 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26672439 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26348236 |
| 49 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26187655 |
| 50 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25508717 |
| 51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24844919 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23109119 |
| 53 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22990358 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21446354 |
| 55 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19806983 |
| 56 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19064188 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14093917 |
| 58 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13483090 |
| 59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10297973 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07861088 |
| 61 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06532449 |
| 62 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05510804 |
| 63 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05510804 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05268510 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05161839 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05149105 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04993317 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03941144 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03161660 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02481888 |
| 71 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02472397 |
| 72 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02012945 |
| 73 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01786266 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01251088 |
| 75 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01120666 |
| 76 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00757916 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00298124 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00016071 |
| 79 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99733418 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99689660 |
| 81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98836237 |
| 82 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.98349550 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98185380 |
| 84 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98087549 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97881171 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96857178 |
| 87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96645455 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 0.95422792 |
| 89 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94073106 |
| 90 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92308319 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91375984 |
| 92 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91150392 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88996727 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88812532 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88183012 |
| 96 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87425274 |
| 97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87127368 |
| 98 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86568186 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85134936 |
| 100 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.84389752 |
| 101 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84004571 |
| 102 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83311574 |
| 103 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.83043106 |
| 104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82784281 |
| 105 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79412474 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78655378 |
| 107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77892117 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76974654 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76606982 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75740125 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75089753 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74248521 |
| 113 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.73723311 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73686774 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.73347548 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.73291111 |
| 117 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.72910160 |
| 118 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72078307 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71257073 |
| 120 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.71086420 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70865409 |
| 122 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.69945151 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69893054 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69246274 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68119174 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.67827538 |
| 127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.67547596 |
| 128 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.66579953 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.65592175 |
| 130 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.65022900 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64454879 |
| 132 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.63487871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.86484519 |
| 2 | MP0005360_urolithiasis | 6.63421295 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.50159801 |
| 4 | MP0005365_abnormal_bile_salt | 5.08455475 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.96167767 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.83071782 |
| 7 | MP0003252_abnormal_bile_duct | 3.42548857 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.33764463 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.99278399 |
| 10 | MP0009840_abnormal_foam_cell | 2.87670058 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.85423894 |
| 12 | MP0005083_abnormal_biliary_tract | 2.80852820 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.71730070 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.63106780 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.53322288 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.47412961 |
| 17 | MP0003195_calcinosis | 2.46995740 |
| 18 | MP0005332_abnormal_amino_acid | 2.45922052 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.29365462 |
| 20 | MP0005623_abnormal_meninges_morphology | 2.14080002 |
| 21 | MP0002254_reproductive_system_inflammat | 2.13850421 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.07526406 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.96229808 |
| 24 | MP0000609_abnormal_liver_physiology | 1.92471244 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.81609959 |
| 26 | MP0003279_aneurysm | 1.72729135 |
| 27 | MP0005409_darkened_coat_color | 1.71342291 |
| 28 | MP0003091_abnormal_cell_migration | 1.68175109 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.65580146 |
| 30 | MP0003941_abnormal_skin_development | 1.63786968 |
| 31 | MP0004858_abnormal_nervous_system | 1.56784085 |
| 32 | MP0005451_abnormal_body_composition | 1.52100736 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.49127949 |
| 34 | MP0000762_abnormal_tongue_morphology | 1.48247156 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.47657888 |
| 36 | MP0004233_abnormal_muscle_weight | 1.46907253 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.41033516 |
| 38 | MP0002796_impaired_skin_barrier | 1.39306902 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.38305639 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.36094544 |
| 41 | MP0005670_abnormal_white_adipose | 1.33280333 |
| 42 | MP0003868_abnormal_feces_composition | 1.31248141 |
| 43 | MP0000733_abnormal_muscle_development | 1.31175952 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.28882213 |
| 45 | MP0000767_abnormal_smooth_muscle | 1.26324850 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.23717177 |
| 47 | MP0000566_synostosis | 1.22992554 |
| 48 | MP0000751_myopathy | 1.22839602 |
| 49 | MP0001958_emphysema | 1.22329756 |
| 50 | MP0000858_altered_metastatic_potential | 1.20412717 |
| 51 | MP0004510_myositis | 1.20203048 |
| 52 | MP0008260_abnormal_autophagy | 1.19734539 |
| 53 | MP0009053_abnormal_anal_canal | 1.18356104 |
| 54 | MP0001915_intracranial_hemorrhage | 1.17880214 |
| 55 | MP0000534_abnormal_ureter_morphology | 1.10797503 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10383173 |
| 57 | MP0000598_abnormal_liver_morphology | 1.07469289 |
| 58 | MP0010771_integument_phenotype | 1.05018715 |
| 59 | MP0005508_abnormal_skeleton_morphology | 1.03340020 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.01999987 |
| 61 | MP0003329_amyloid_beta_deposits | 1.01119829 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 0.98270964 |
| 63 | MP0005197_abnormal_uvea_morphology | 0.97950596 |
| 64 | MP0003942_abnormal_urinary_system | 0.97826944 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 0.94116402 |
| 66 | MP0001756_abnormal_urination | 0.93296945 |
| 67 | MP0004185_abnormal_adipocyte_glucose | 0.93037279 |
| 68 | MP0000462_abnormal_digestive_system | 0.91730096 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 0.91410168 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.91180678 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.90177854 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.89572079 |
| 73 | MP0003011_delayed_dark_adaptation | 0.89471108 |
| 74 | MP0000013_abnormal_adipose_tissue | 0.89246255 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.89212168 |
| 76 | MP0004130_abnormal_muscle_cell | 0.87166337 |
| 77 | MP0002971_abnormal_brown_adipose | 0.84747101 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.84179103 |
| 79 | MP0001243_abnormal_dermal_layer | 0.81993702 |
| 80 | MP0002060_abnormal_skin_morphology | 0.81768106 |
| 81 | MP0010678_abnormal_skin_adnexa | 0.81335045 |
| 82 | MP0003186_abnormal_redox_activity | 0.81253845 |
| 83 | MP0009672_abnormal_birth_weight | 0.80887320 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.80069269 |
| 85 | MP0000579_abnormal_nail_morphology | 0.79974982 |
| 86 | MP0004043_abnormal_pH_regulation | 0.77987163 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.77914392 |
| 88 | MP0005501_abnormal_skin_physiology | 0.77789532 |
| 89 | MP0005330_cardiomyopathy | 0.77717657 |
| 90 | MP0003385_abnormal_body_wall | 0.77334670 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.76314954 |
| 92 | MP0001764_abnormal_homeostasis | 0.76251718 |
| 93 | MP0005193_abnormal_anterior_eye | 0.75464669 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.74039761 |
| 95 | MP0000627_abnormal_mammary_gland | 0.73792710 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.71812520 |
| 97 | MP0005647_abnormal_sex_gland | 0.71014162 |
| 98 | MP0005023_abnormal_wound_healing | 0.70564578 |
| 99 | MP0000377_abnormal_hair_follicle | 0.70561553 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.70494199 |
| 101 | MP0001730_embryonic_growth_arrest | 0.70419868 |
| 102 | MP0009642_abnormal_blood_homeostasis | 0.70104362 |
| 103 | MP0009931_abnormal_skin_appearance | 0.70073404 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.69470563 |
| 105 | MP0001542_abnormal_bone_strength | 0.69346677 |
| 106 | MP0001661_extended_life_span | 0.69175072 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.68045177 |
| 108 | MP0005165_increased_susceptibility_to | 0.68001504 |
| 109 | MP0000747_muscle_weakness | 0.67502268 |
| 110 | MP0001614_abnormal_blood_vessel | 0.67201242 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.66902319 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.66070886 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.65601558 |
| 114 | MP0000759_abnormal_skeletal_muscle | 0.65569063 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.65339871 |
| 116 | MP0004947_skin_inflammation | 0.64851989 |
| 117 | MP0005621_abnormal_cell_physiology | 0.64515224 |
| 118 | MP0005275_abnormal_skin_tensile | 0.64501446 |
| 119 | MP0005408_hypopigmentation | 0.64436594 |
| 120 | MP0000538_abnormal_urinary_bladder | 0.64212328 |
| 121 | MP0000537_abnormal_urethra_morphology | 0.63650883 |
| 122 | MP0005503_abnormal_tendon_morphology | 0.62820422 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.62738908 |
| 124 | MP0002098_abnormal_vibrissa_morphology | 0.61514579 |
| 125 | MP0010352_gastrointestinal_tract_polyps | 0.60501595 |
| 126 | MP0009763_increased_sensitivity_to | 0.60437613 |
| 127 | MP0002269_muscular_atrophy | 0.60033560 |
| 128 | MP0004087_abnormal_muscle_fiber | 0.57342516 |
| 129 | MP0010630_abnormal_cardiac_muscle | 0.57254133 |
| 130 | MP0006138_congestive_heart_failure | 0.57231695 |
| 131 | MP0003300_gastrointestinal_ulcer | 0.56357796 |
| 132 | MP0005084_abnormal_gallbladder_morpholo | 0.55791804 |
| 133 | MP0002822_catalepsy | 0.55467021 |
| 134 | MP0001849_ear_inflammation | 0.54404667 |
| 135 | MP0005334_abnormal_fat_pad | 0.53299539 |
| 136 | MP0010030_abnormal_orbit_morphology | 0.53001292 |
| 137 | MP0004272_abnormal_basement_membrane | 0.52931194 |
| 138 | MP0000467_abnormal_esophagus_morphology | 0.51914192 |
| 139 | MP0005076_abnormal_cell_differentiation | 0.51684442 |
| 140 | MP0005395_other_phenotype | 0.50934769 |
| 141 | MP0009764_decreased_sensitivity_to | 0.50637832 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.49973393 |
| 143 | MP0003283_abnormal_digestive_organ | 0.49204653 |
| 144 | MP0003115_abnormal_respiratory_system | 0.49201017 |
| 145 | MP0005266_abnormal_metabolism | 0.49122245 |
| 146 | MP0005376_homeostasis/metabolism_phenot | 0.48220784 |
| 147 | MP0005448_abnormal_energy_balance | 0.47811577 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.47710528 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.47481815 |
| 150 | MP0002234_abnormal_pharynx_morphology | 0.47032064 |
| 151 | MP0001944_abnormal_pancreas_morphology | 0.45686121 |
| 152 | MP0008469_abnormal_protein_level | 0.44717283 |
| 153 | MP0003119_abnormal_digestive_system | 0.43839230 |
| 154 | MP0002249_abnormal_larynx_morphology | 0.43675777 |
| 155 | MP0001216_abnormal_epidermal_layer | 0.43085740 |
| 156 | MP0000604_amyloidosis | 0.42344360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.30015125 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.14860921 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.99561698 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.74373641 |
| 5 | Xanthomatosis (HP:0000991) | 5.45437275 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.03002591 |
| 7 | Premature rupture of membranes (HP:0001788) | 4.91989407 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.71566245 |
| 9 | Protrusio acetabuli (HP:0003179) | 4.42701493 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.40717853 |
| 11 | Complement deficiency (HP:0004431) | 4.37707932 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09978726 |
| 13 | Hyperammonemia (HP:0001987) | 4.05525325 |
| 14 | Hypoglycemic coma (HP:0001325) | 4.03654288 |
| 15 | Ketosis (HP:0001946) | 3.99731291 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.97168049 |
| 17 | Hyperglycinuria (HP:0003108) | 3.77936050 |
| 18 | Epidermoid cyst (HP:0200040) | 3.71683706 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.70646597 |
| 20 | Joint hemorrhage (HP:0005261) | 3.70235489 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.67341139 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.65323048 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.61456124 |
| 24 | Hyperglycinemia (HP:0002154) | 3.51779859 |
| 25 | Gout (HP:0001997) | 3.50098183 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.46637127 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.42467489 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.42467489 |
| 29 | Ketoacidosis (HP:0001993) | 3.41506801 |
| 30 | Fat malabsorption (HP:0002630) | 3.40063387 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.39022904 |
| 32 | Vertebral compression fractures (HP:0002953) | 3.34472633 |
| 33 | Abnormality of complement system (HP:0005339) | 3.31533256 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20809128 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.09090024 |
| 36 | Fragile skin (HP:0001030) | 3.05615764 |
| 37 | Atrophic scars (HP:0001075) | 3.04622792 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 3.02464709 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 2.95539858 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.94041566 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 2.93569425 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87927628 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85919974 |
| 44 | Short nail (HP:0001799) | 2.85189286 |
| 45 | Hyperacusis (HP:0010780) | 2.83131408 |
| 46 | Arterial tortuosity (HP:0005116) | 2.82219320 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.80812363 |
| 48 | Myocardial infarction (HP:0001658) | 2.80503643 |
| 49 | Cervical subluxation (HP:0003308) | 2.78795684 |
| 50 | Ulnar bowing (HP:0003031) | 2.78316879 |
| 51 | Distal upper limb amyotrophy (HP:0007149) | 2.77966629 |
| 52 | Upper limb amyotrophy (HP:0009129) | 2.77966629 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.74306779 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.70621072 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.68492940 |
| 56 | Vascular tortuosity (HP:0004948) | 2.66376545 |
| 57 | Vascular calcification (HP:0004934) | 2.64599637 |
| 58 | Skin nodule (HP:0200036) | 2.62800590 |
| 59 | Hyperbilirubinemia (HP:0002904) | 2.62273600 |
| 60 | Distal lower limb muscle weakness (HP:0009053) | 2.62014250 |
| 61 | Late onset (HP:0003584) | 2.60915687 |
| 62 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.57878180 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.57047386 |
| 64 | Aortic dissection (HP:0002647) | 2.56907742 |
| 65 | Spinal rigidity (HP:0003306) | 2.56533181 |
| 66 | Ankle contracture (HP:0006466) | 2.54012958 |
| 67 | Esophageal varix (HP:0002040) | 2.53850079 |
| 68 | Natal tooth (HP:0000695) | 2.50955972 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.50917623 |
| 70 | Hypochromic microcytic anemia (HP:0004840) | 2.49473787 |
| 71 | Axonal loss (HP:0003447) | 2.48787560 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.47815307 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.44073295 |
| 74 | Malnutrition (HP:0004395) | 2.42553250 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.42346979 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39158315 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.39158315 |
| 78 | Elbow flexion contracture (HP:0002987) | 2.38851577 |
| 79 | Flat acetabular roof (HP:0003180) | 2.38437926 |
| 80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37732078 |
| 81 | Steatorrhea (HP:0002570) | 2.37350119 |
| 82 | Shallow orbits (HP:0000586) | 2.35106558 |
| 83 | Neonatal onset (HP:0003623) | 2.34334283 |
| 84 | Bladder diverticulum (HP:0000015) | 2.33979136 |
| 85 | Metabolic acidosis (HP:0001942) | 2.33774371 |
| 86 | Broad face (HP:0000283) | 2.33614563 |
| 87 | Spontaneous abortion (HP:0005268) | 2.32266693 |
| 88 | Increased connective tissue (HP:0009025) | 2.32050049 |
| 89 | Spastic diplegia (HP:0001264) | 2.30951333 |
| 90 | Abnormal cartilage morphology (HP:0002763) | 2.28797758 |
| 91 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28131137 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28131137 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28131137 |
| 94 | Hyperuricemia (HP:0002149) | 2.27577337 |
| 95 | Increased purine levels (HP:0004368) | 2.27577337 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26739847 |
| 97 | Polycythemia (HP:0001901) | 2.26540807 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.25948251 |
| 99 | Advanced eruption of teeth (HP:0006288) | 2.22860823 |
| 100 | Cholelithiasis (HP:0001081) | 2.21525932 |
| 101 | Hydroxyprolinuria (HP:0003080) | 2.21403924 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 2.21403924 |
| 103 | Abnormal gallbladder morphology (HP:0012437) | 2.18185263 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 2.17987764 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.17987764 |
| 106 | Hyperglycemia (HP:0003074) | 2.17665345 |
| 107 | Abnormality of carpal bone ossification (HP:0006257) | 2.12766725 |
| 108 | Blue sclerae (HP:0000592) | 2.12449256 |
| 109 | Wormian bones (HP:0002645) | 2.12389318 |
| 110 | Lethargy (HP:0001254) | 2.12382675 |
| 111 | Thin bony cortex (HP:0002753) | 2.12074164 |
| 112 | Sensorimotor neuropathy (HP:0007141) | 2.09361146 |
| 113 | Nuclear cataract (HP:0100018) | 2.07157040 |
| 114 | Aortic aneurysm (HP:0004942) | 2.06785385 |
| 115 | Disproportionate tall stature (HP:0001519) | 2.06401742 |
| 116 | Irritability (HP:0000737) | 2.05103550 |
| 117 | Turricephaly (HP:0000262) | 2.01479669 |
| 118 | Myoglobinuria (HP:0002913) | 2.01000168 |
| 119 | Rickets (HP:0002748) | 2.00178616 |
| 120 | Hand muscle atrophy (HP:0009130) | 1.99589757 |
| 121 | Abnormality of the acetabulum (HP:0003170) | 1.98654004 |
| 122 | Systemic lupus erythematosus (HP:0002725) | 1.98328431 |
| 123 | Trismus (HP:0000211) | 1.98191826 |
| 124 | Hemorrhage of the eye (HP:0011885) | 1.97992143 |
| 125 | Abnormal ossification of hand bones (HP:0005921) | 1.97634639 |
| 126 | Neonatal death (HP:0003811) | 1.96578264 |
| 127 | Glomerulosclerosis (HP:0000096) | 1.96338455 |
| 128 | Abnormality of dentin (HP:0010299) | 1.95268137 |
| 129 | Mitral regurgitation (HP:0001653) | 1.94728485 |
| 130 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91531844 |
| 131 | Hyperparathyroidism (HP:0000843) | 1.91403217 |
| 132 | Abnormality of nail color (HP:0100643) | 1.91176162 |
| 133 | Proximal tubulopathy (HP:0000114) | 1.91173489 |
| 134 | Abnormality of the Achilles tendon (HP:0005109) | 1.90154958 |
| 135 | Alkalosis (HP:0001948) | 1.89057777 |
| 136 | Generalized amyotrophy (HP:0003700) | 1.88256596 |
| 137 | Difficulty climbing stairs (HP:0003551) | 1.87034455 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86140801 |
| 139 | Mucopolysacchariduria (HP:0008155) | 1.86140801 |
| 140 | Back pain (HP:0003418) | 1.85230219 |
| 141 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84755403 |
| 142 | Mitral valve prolapse (HP:0001634) | 1.83756714 |
| 143 | Cerebral inclusion bodies (HP:0100314) | 1.83353171 |
| 144 | Abnormal gallbladder physiology (HP:0012438) | 1.83264296 |
| 145 | Cholecystitis (HP:0001082) | 1.83264296 |
| 146 | Aneurysm (HP:0002617) | 1.83193109 |
| 147 | Abnormality of the gallbladder (HP:0005264) | 1.82946902 |
| 148 | Neonatal short-limb short stature (HP:0008921) | 1.82666686 |
| 149 | Acanthosis nigricans (HP:0000956) | 1.81548097 |
| 150 | Symptomatic seizures (HP:0011145) | 1.81403406 |
| 151 | Neurofibrillary tangles (HP:0002185) | 1.80670683 |
| 152 | Vomiting (HP:0002013) | 1.80657359 |
| 153 | Long toe (HP:0010511) | 1.80254846 |
| 154 | Alopecia of scalp (HP:0002293) | 1.79497434 |
| 155 | Asymmetry of the thorax (HP:0001555) | 1.79459875 |
| 156 | Genu recurvatum (HP:0002816) | 1.79119954 |
| 157 | Acanthocytosis (HP:0001927) | 1.78782064 |
| 158 | Bowed forearm bones (HP:0003956) | 1.78314365 |
| 159 | Bowing of the arm (HP:0006488) | 1.78314365 |
| 160 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77992019 |
| 161 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77992019 |
| 162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77992019 |
| 163 | Renal duplication (HP:0000075) | 1.77517664 |
| 164 | Lower limb amyotrophy (HP:0007210) | 1.76853405 |
| 165 | Selective tooth agenesis (HP:0001592) | 1.76080536 |
| 166 | Pancreatitis (HP:0001733) | 1.74917873 |
| 167 | Insomnia (HP:0100785) | 1.74733899 |
| 168 | Enlarged kidneys (HP:0000105) | 1.74502090 |
| 169 | Spondylolisthesis (HP:0003302) | 1.74455708 |
| 170 | Dysostosis multiplex (HP:0000943) | 1.74242735 |
| 171 | Stridor (HP:0010307) | 1.74126062 |
| 172 | Lymphangioma (HP:0100764) | 1.73779733 |
| 173 | Spinal cord compression (HP:0002176) | 1.72202048 |
| 174 | Soft skin (HP:0000977) | 1.69477259 |
| 175 | Reticulocytosis (HP:0001923) | 1.68692968 |
| 176 | Nephrolithiasis (HP:0000787) | 1.68515601 |
| 177 | Coxa vara (HP:0002812) | 1.67928372 |
| 178 | Mitral stenosis (HP:0001718) | 1.67826196 |
| 179 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.67780755 |
| 180 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.67780755 |
| 181 | Abnormality of the umbilical cord (HP:0010881) | 1.66124571 |
| 182 | Ileus (HP:0002595) | 1.65697876 |
| 183 | Pterygium (HP:0001059) | 1.65310284 |
| 184 | Long palpebral fissure (HP:0000637) | 1.64099975 |
| 185 | Congenital glaucoma (HP:0001087) | 1.63760054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.98884578 |
| 2 | IRAK3 | 3.87881082 |
| 3 | TRIB3 | 3.83542767 |
| 4 | ERN1 | 3.62754484 |
| 5 | PKN2 | 3.16644208 |
| 6 | LATS1 | 2.85149764 |
| 7 | EPHA2 | 2.77086215 |
| 8 | SIK1 | 2.63055636 |
| 9 | NME2 | 2.55353218 |
| 10 | FGFR4 | 2.54751457 |
| 11 | MAP3K3 | 2.18462389 |
| 12 | PTK6 | 2.13785272 |
| 13 | ERBB4 | 2.04009407 |
| 14 | SMG1 | 2.01459661 |
| 15 | TESK1 | 1.94917734 |
| 16 | MAP3K10 | 1.91296862 |
| 17 | EEF2K | 1.81788048 |
| 18 | MST1R | 1.72393261 |
| 19 | LMTK2 | 1.70168048 |
| 20 | MAP3K2 | 1.66568428 |
| 21 | RIPK1 | 1.65302360 |
| 22 | MAP2K2 | 1.63874805 |
| 23 | STK38L | 1.58970766 |
| 24 | TAOK1 | 1.47957332 |
| 25 | TBK1 | 1.45531296 |
| 26 | NTRK1 | 1.43553214 |
| 27 | EPHB2 | 1.42905859 |
| 28 | PTK2 | 1.41469264 |
| 29 | INSRR | 1.38425889 |
| 30 | ARAF | 1.37249223 |
| 31 | MAPK15 | 1.36648443 |
| 32 | LATS2 | 1.35913595 |
| 33 | TAOK3 | 1.33397243 |
| 34 | MAP3K9 | 1.32065157 |
| 35 | TTN | 1.28206754 |
| 36 | MAPK11 | 1.26915302 |
| 37 | MAPKAPK3 | 1.26572779 |
| 38 | PIM2 | 1.20670876 |
| 39 | ICK | 1.20291223 |
| 40 | PDGFRA | 1.18114621 |
| 41 | LIMK1 | 1.14393182 |
| 42 | MAP3K7 | 1.13155715 |
| 43 | BMX | 1.12357027 |
| 44 | CDC42BPA | 1.12330212 |
| 45 | PRPF4B | 1.11513628 |
| 46 | DYRK1B | 1.10930115 |
| 47 | FLT3 | 1.03665913 |
| 48 | MAP2K3 | 1.03033023 |
| 49 | MTOR | 1.02354054 |
| 50 | MET | 1.01337656 |
| 51 | EPHB1 | 1.01292585 |
| 52 | MAP3K11 | 0.97661585 |
| 53 | NEK9 | 0.96312940 |
| 54 | CDK12 | 0.94620117 |
| 55 | TGFBR2 | 0.91398514 |
| 56 | PAK4 | 0.90613846 |
| 57 | CDK6 | 0.89503466 |
| 58 | WNK4 | 0.89377460 |
| 59 | PRKAA2 | 0.89110783 |
| 60 | CDK8 | 0.88387362 |
| 61 | MAP2K1 | 0.83127275 |
| 62 | DAPK2 | 0.80365603 |
| 63 | WNK3 | 0.77353277 |
| 64 | GSK3A | 0.76974442 |
| 65 | MOS | 0.73774061 |
| 66 | PAK3 | 0.72563195 |
| 67 | LRRK2 | 0.72306957 |
| 68 | RPS6KA2 | 0.71892096 |
| 69 | STK38 | 0.71522571 |
| 70 | KSR2 | 0.71120675 |
| 71 | PRKD3 | 0.70951468 |
| 72 | BRAF | 0.69211930 |
| 73 | MAP3K12 | 0.68810014 |
| 74 | STK3 | 0.68669014 |
| 75 | FER | 0.66790721 |
| 76 | MAP2K4 | 0.66477990 |
| 77 | ABL2 | 0.66336183 |
| 78 | SCYL2 | 0.66181508 |
| 79 | MAP3K6 | 0.66172146 |
| 80 | PRKD1 | 0.65595711 |
| 81 | ERBB2 | 0.65395604 |
| 82 | PRKG2 | 0.65147988 |
| 83 | PRKAA1 | 0.64140558 |
| 84 | PDPK1 | 0.63756350 |
| 85 | RPS6KB2 | 0.63474277 |
| 86 | DAPK3 | 0.62589753 |
| 87 | SGK3 | 0.61302964 |
| 88 | PDGFRB | 0.60292905 |
| 89 | RPS6KA1 | 0.59669792 |
| 90 | IRAK2 | 0.58272217 |
| 91 | RPS6KA4 | 0.56752844 |
| 92 | CHUK | 0.56150972 |
| 93 | MAP3K1 | 0.55819849 |
| 94 | JAK2 | 0.55747769 |
| 95 | CDK9 | 0.54469590 |
| 96 | IKBKE | 0.53844025 |
| 97 | PIK3CG | 0.53680465 |
| 98 | RET | 0.52462458 |
| 99 | TIE1 | 0.52433550 |
| 100 | GRK6 | 0.52025179 |
| 101 | TRPM7 | 0.51160829 |
| 102 | PRKCZ | 0.51114237 |
| 103 | MAP3K8 | 0.50680793 |
| 104 | FRK | 0.49768802 |
| 105 | ILK | 0.48307649 |
| 106 | NEK1 | 0.47325535 |
| 107 | FGFR3 | 0.46809578 |
| 108 | MARK2 | 0.46216413 |
| 109 | DDR2 | 0.46033113 |
| 110 | CAMK2G | 0.45605882 |
| 111 | CAMK1D | 0.44859342 |
| 112 | FGFR1 | 0.44053599 |
| 113 | ROCK2 | 0.43715646 |
| 114 | CDK4 | 0.43561834 |
| 115 | DMPK | 0.43463976 |
| 116 | MELK | 0.43088182 |
| 117 | PAK2 | 0.41134777 |
| 118 | RPS6KC1 | 0.41052866 |
| 119 | RPS6KL1 | 0.41052866 |
| 120 | AKT2 | 0.40756753 |
| 121 | MYLK | 0.40040850 |
| 122 | CDK7 | 0.40003372 |
| 123 | STK24 | 0.39961135 |
| 124 | FGFR2 | 0.39844238 |
| 125 | TESK2 | 0.39565884 |
| 126 | PRKCI | 0.39407991 |
| 127 | AURKA | 0.39002793 |
| 128 | RPS6KA6 | 0.38955477 |
| 129 | STK10 | 0.38904226 |
| 130 | ROCK1 | 0.38787476 |
| 131 | MAP3K5 | 0.37126699 |
| 132 | MAPK7 | 0.35490626 |
| 133 | TAOK2 | 0.34774355 |
| 134 | PRKACG | 0.34705834 |
| 135 | PRKD2 | 0.34658504 |
| 136 | TYK2 | 0.34323271 |
| 137 | MAP3K13 | 0.33199522 |
| 138 | PBK | 0.32043488 |
| 139 | PAK1 | 0.30792627 |
| 140 | MUSK | 0.29939256 |
| 141 | CAMK1G | 0.29060451 |
| 142 | MAPKAPK2 | 0.27835568 |
| 143 | CAMK2D | 0.26294722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99869405 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.56633573 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31967271 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.26767187 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98336617 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71516333 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.70122084 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66818315 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.62938601 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44274093 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.40947690 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.35727644 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.35577244 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32918713 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16140368 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03285584 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01366673 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00931436 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97565529 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95858439 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.86316584 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85896543 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84955708 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.78060535 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77129795 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67331230 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.66451401 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65117665 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62955692 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.62904809 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62103405 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58357204 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.57094402 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56080246 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.55379935 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.55119694 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49887058 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49838271 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48944769 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46907897 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46622263 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44687987 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44009947 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38141126 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.35058622 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33962216 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31510196 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31158287 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30076261 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29732226 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26086042 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25831314 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25086891 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25006458 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22242906 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21003586 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20443790 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19688791 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18292938 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 1.16137688 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11945539 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 1.11801706 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10975396 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09245634 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 1.09036569 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02414002 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00869758 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.00778695 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00605437 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99028742 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96607819 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95495059 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.95338569 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94562293 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90621121 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89444494 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89285414 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88851621 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86239031 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86051931 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85394192 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.85326487 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.84657635 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77909343 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.77749289 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76980939 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75504953 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74888916 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.74063875 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.73533085 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73417967 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72635250 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70523209 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69332512 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68045316 |
| 96 | Axon guidance_Homo sapiens_hsa04360 | 0.66700114 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66111530 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64078443 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63870545 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62989135 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59831728 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.59486140 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58529280 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58464345 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.57842031 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55296910 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54458538 |
| 108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53826149 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53260424 |
| 110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53023533 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53013508 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.49110142 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48680896 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48437081 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45250531 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44438953 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.43950491 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43377141 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.43124479 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40482609 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.40206077 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38603489 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38567049 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33462971 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31829742 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29369328 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29087489 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23466212 |
| 129 | Adherens junction_Homo sapiens_hsa04520 | 0.17340533 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16688057 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15907437 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.14877812 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14271310 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13938110 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12532521 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09510536 |
| 137 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.08612326 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07515987 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.07089836 |
| 140 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.04728425 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.04626650 |
| 142 | Tight junction_Homo sapiens_hsa04530 | 0.04113070 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.03062211 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02715428 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.02096289 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00719892 |
| 147 | Focal adhesion_Homo sapiens_hsa04510 | 0.00115388 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.00076340 |
| 149 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0414370 |
| 150 | Hippo signaling pathway_Homo sapiens_hsa04390 | -0.0180951 |

